{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:19:49Z","timestamp":1782865189438,"version":"3.54.5"},"update-to":[{"DOI":"10.1002\/14651858.cd006978","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T00:00:00Z","timestamp":1481155200000}}],"reference-count":43,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006978.pub2","type":"journal-article","created":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T23:26:09Z","timestamp":1481239569000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Antibiotics for the neurological complications of Lyme disease"],"prefix":"10.1002","volume":"2016","author":[{"given":"Diego","family":"Cadavid","sequence":"first","affiliation":[{"name":"Fulcrum Therapeutics; One Kendall Square Building 700, Suite B7102 Cambridge MA USA 02139"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G","family":"Auwaerter","sequence":"additional","affiliation":[{"name":"John Hopkins University School of Medicine; Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases; 725 N. Wolfe Street, PTCB - Rm 231 Baltimore MD USA 21287"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Rumbaugh","sequence":"additional","affiliation":[{"name":"Watson Clinic; 1600 Lakeland Hills Blvd Lakeland FL USA 33805"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Gelderblom","sequence":"additional","affiliation":[{"name":"National Association of Statutory Health Insurance Funds; Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,12,8]]},"reference":[{"issue":"7","key":"10.1002\/14651858.CD006978.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1212\/WNL.44.7.1203","article-title":"Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis","volume":"44","author":"Karlsson","year":"1994","journal-title":"Neurology"},{"issue":"8","key":"10.1002\/14651858.CD006978.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/BF00328508","article-title":"Treatment of Lyme borreliosis, randomized comparison of doxycycline and penicillin G","volume":"236","author":"Kohlhepp","year":"1989","journal-title":"Journal of Neurology"},{"issue":"8","key":"10.1002\/14651858.CD006978.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S1474-4422(08)70119-4","article-title":"Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicenter, non-inferiority, double-blind, randomized trial","volume":"7","author":"Ljostad","year":"2008","journal-title":"Lancet Neurology"},{"issue":"4","key":"10.1002\/14651858.CD006978.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF01644967","article-title":"Penicillin G sodium and ceftriaxone in the treatment of neuroborreliosis in children\u2014a prospective study","volume":"19","author":"Mullegger","year":"1991","journal-title":"Infection"},{"key":"10.1002\/14651858.CD006978.pub2-BIB0006|cit5","unstructured":"Oksi J VS: Cochrane Review: Neuroborreliosis Email to: P Auwaerter"},{"issue":"8","key":"10.1002\/14651858.CD006978.pub2-BIB0005|cit6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10096-007-0340-2","article-title":"Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study","volume":"26","author":"Oksi","year":"2007","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"issue":"11","key":"10.1002\/14651858.CD006978.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archneur.1989.00520470044025","article-title":"Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis. A prospective randomized study","volume":"46","author":"Pfister","year":"1989","journal-title":"Archives of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD006978.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/infdis\/163.2.311","article-title":"Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis","volume":"163","author":"Pfister","year":"1991","journal-title":"Journal of Infectious Diseases"},{"issue":"8596","key":"10.1002\/14651858.CD006978.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(88)92011-9","article-title":"Treatment of late Lyme borreliosis\u2014randomised comparison of ceftriaxone and penicillin","volume":"1","author":"Dattwyler","year":"1988","journal-title":"Lancet"},{"issue":"11-12","key":"10.1002\/14651858.CD006978.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00508-005-0361-8","article-title":"A comparison of two treatment regimens of ceftriaxone in late Lyme disease","volume":"117","author":"Dattwyler","year":"2005","journal-title":"Wiener Klinische Wochenschrift"},{"issue":"1","key":"10.1002\/14651858.CD006978.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF01644175","article-title":"Cefotaxime versus penicillin in the late stage of Lyme disease\u2014prospective, randomized therapeutic study","volume":"18","author":"Hassler","year":"1990","journal-title":"Infection"},{"issue":"4","key":"10.1002\/14651858.CD006978.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0002-9343(92)90270-L","article-title":"Treatment of early Lyme disease","volume":"92","author":"Massarotti","year":"1992","journal-title":"American Journal of Medicine"},{"issue":"10","key":"10.1002\/14651858.CD006978.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s100960050166","article-title":"Comparison of oral cefixime and intravenous ceftriaxone followed by oral amoxicillin in disseminated Lyme borreliosis","volume":"17","author":"Oksi","year":"1998","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD006978.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1749-6632.1988.tb31915.x","article-title":"Corticosteroids for radicular pain in Bannwarth's syndrome: a double-blind randomized placebo-controlled trial","volume":"539","author":"Pfister","year":"1988","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1002\/14651858.CD006978.pub2-BIB0015|cit15","unstructured":"NCT02553473 Six versus two weeks treatment with doxycycline in Lyme neuroborreliosis; a multicenter, non-inferiority, penta-blind, randomized trial clinicaltrials.gov\/ct2\/show\/NCT02553473"},{"issue":"31","key":"10.1002\/14651858.CD006978.pub2-BIB0016|cit16","first-page":"590","article-title":"Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease","volume":"44","year":"1995","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"2","key":"10.1002\/14651858.CD006978.pub2-BIB0017|cit17","first-page":"284","volume":"113","author":"Bannwarth","year":"1941","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"issue":"3","key":"10.1002\/14651858.CD006978.pub2-BIB0018|cit18","first-page":"682","volume":"117","author":"Bannwarth","year":"1944","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"issue":"4552","key":"10.1002\/14651858.CD006978.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.7043737","article-title":"Lyme disease\u2014a tick-borne spirochetosis?","volume":"216","author":"Burgdorfer","year":"1982","journal-title":"Science"},{"issue":"9","key":"10.1002\/14651858.CD006978.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1586\/14787210.2014.940900","article-title":"Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease","volume":"12","author":"Cameron","year":"2014","journal-title":"Expert Review of Anti-infective Therapy"},{"key":"10.1002\/14651858.CD006978.pub2-BIB0021|cit21","unstructured":"Centers for Disease Control and Prevention Clinical manifestations of confirmed Lyme disease cases\u2014United States, 2001-2010 www.cdc.gov\/lyme\/stats\/graphs.html"},{"key":"10.1002\/14651858.CD006978.pub2-BIB0022|cit22","unstructured":"Centers for Disease Control and Prevention Lyme disease ( Borrelia burgdorferi ): 2011 case definition wwwn.cdc.gov\/nndss\/conditions\/lyme-disease\/case-definition\/2011\/"},{"issue":"9","key":"10.1002\/14651858.CD006978.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/ene.12744","article-title":"Efficacy and safety of pharmacological treatments for acute Lyme neuroborreliosis\u2014a systematic review","volume":"22","author":"Dersch","year":"2015","journal-title":"European Journal of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD006978.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/infdis\/167.2.392","article-title":"Western blotting in the serodiagnosis of Lyme disease","volume":"167","author":"Dressler","year":"1993","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD006978.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1128\/jcm.33.2.419-427.1995","article-title":"Immunoblot interpretation criteria for serodiagnosis of early Lyme disease","volume":"33","author":"Engstrom","year":"1995","journal-title":"Journal of Clinical Microbiology"},{"key":"10.1002\/14651858.CD006978.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"GRADE Working Group","year":"2004","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD006978.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1212\/WNL.46.3.619","article-title":"Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Quality Standards Subcommittee of the American Academy of Neurology","volume":"46","author":"Halperin","year":"1996","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD006978.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1212\/01.wnl.0000265517.66976.28","article-title":"Practice Parameter: Treatment of nervous system Lyme disease (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"69","author":"Halperin","year":"2007","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD006978.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.idc.2015.02.002","article-title":"Nervous system Lyme disease","volume":"29","author":"Halperin","year":"2015","journal-title":"Infectious Disease Clinics of North America"},{"issue":"2","key":"10.1002\/14651858.CD006978.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/brain\/115.2.399","article-title":"The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production","volume":"115","author":"Hansen","year":"1992","journal-title":"Brain"},{"key":"10.1002\/14651858.CD006978.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/B978-0-444-52902-2.00032-1","article-title":"Chapter 32 - Lyme neuroborreliosis","volume-title":"Peripheral Nerve Disorders Vol 115 (3rd series), Handbook of Clinical Neurology","author":"Hansen","year":"2013"},{"key":"10.1002\/14651858.CD006978.pub2-BIB0032|cit32","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"2","key":"10.1002\/14651858.CD006978.pub2-BIB0033|cit33","first-page":"235","article-title":"Successful treatment of erythema chronicum migrans Afzelius","volume":"31","author":"Hollstrom","year":"1951","journal-title":"Acta Dermato-Venereologica"},{"issue":"1","key":"10.1002\/14651858.CD006978.pub2-BIB0034|cit34","first-page":"453\u201360","article-title":"Evaluation of study patients with Lyme disease, 10\u201320-year follow-up","volume":"183","author":"Kalish","year":"2001","journal-title":"Journal of Infectious Diseases"},{"issue":"8","key":"10.1002\/14651858.CD006978.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nrneurol.2015.121","article-title":"Lyme neuroborreliosis\u2014epidemiology, diagnosis and management","volume":"11","author":"Koedel","year":"2015","journal-title":"Nature Reviews Neurology"},{"issue":"6","key":"10.1002\/14651858.CD006978.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/BF00314373","article-title":"Meningoradiculitis and encephalomyelitis due to Borrelia burgdorferi: a follow-up study of 72 patients over 27 years","volume":"236","author":"Kr\u00fcger","year":"1989","journal-title":"Journal of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD006978.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"8-16; e1-14","DOI":"10.1111\/j.1468-1331.2009.02862.x","article-title":"EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis","volume":"17","author":"Mygland","year":"2010","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD006978.pub2-BIB0038|cit38","unstructured":"Rauer S Neuroborreliosis guidelines from the German Neurological Society Deutsche Gesellschaft f\u00fcr Neurologie September 2012"},{"key":"10.1002\/14651858.CD006978.pub2-BIB0039|cit39","unstructured":"Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"6","key":"10.1002\/14651858.CD006978.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/infdis\/161.6.1203","article-title":"Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis","volume":"161","author":"Steere","year":"1990","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD006978.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1749-6632.1988.tb31837.x","article-title":"Clinical manifestations and diagnosis of neuroborreliosis","volume":"539","author":"Stiernstedt","year":"1988","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1002\/14651858.CD006978.pub2-BIB0042|cit42","first-page":"1","article-title":"MIQ 12, Lyme-Borreliose","volume-title":"Qualit\u00e4tsstandards in der mikrobiologisch-infektiologischen Diagnostik","author":"Wilske","year":"2000"},{"issue":"1","key":"10.1002\/14651858.CD006978.pub2-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006978","article-title":"Treatment for the neurological complications of Lyme disease","author":"Cadavid","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD006978.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T06:44:16Z","timestamp":1725950656000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006978.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Neuromuscular Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,12,8]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006978.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,8]]}}}